ADMA Biologics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has ADMA Biologics's balance sheet done over the years? Its assets were worth $329,182,000 last year, which is less than in the previous period. 59% of ADMA Biologics’s total assets is currently financed by debt. Its liabilities reached the amount of $193,976,000, which means an decrease by -1% compared compared to last year.
Debt to Assets
| 2014 | 27227497 | 21.21M | 77.93% |
|---|---|---|---|
| 2015 | 23714517 | 22.89M | 96.54% |
| 2016 | 23685085 | 28.14M | 118.82% |
| 2017 | 108018833 | 67.68M | 62.66% |
| 2018 | 88876521 | 69.10M | 77.76% |
| 2019 | 127090725 | 100.89M | 79.39% |
| 2020 | 207673394 | 119.42M | 57.51% |
| 2021 | 276252724 | 135.08M | 48.9% |
| 2022 | 348461881 | 196.48M | 56.39% |
| 2023 | 329182000 | 193.97M | 58.93% |
ADMA Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 51.35M | 86.52M | 51.08M | 55.92M | 26.75M | 22.75M | 43.10M | 9.91M | 10.44M | 17.19M |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.39M | 6.36M | 4.65M |
Net receivables | 27.42M | 15.50M | 28.57M | 13.23M | 3.46M | 1.39M | 3.88M | 1.01M | 924.46K | 383.96K |
Inventory | 172.90M | 163.28M | 124.72M | 81.53M | 53.06M | 18.61M | 12.62M | 5.02M | 3.44M | 1.70M |
Other current assets | 5.33M | 5.09M | 4.33M | 3.04M | 2.53M | 1.76M | 3.27M | 313.91K | 111.02K | 143.58K |
Total current assets | 257.01M | 270.40M | 208.72M | 153.74M | 85.82M | 44.52M | 63.16M | 21.65M | 21.29M | 24.08M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 63.47M | 68.74M | 58.19M | 45.85M | 31.74M | 30.11M | 30.46M | 2.00M | 2.39M | 2.84M |
Goodwill | 3.53M | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 3.52M | 0 | 0 | 0 |
Intangible assets | 499K | 1.01M | 1.72M | 2.44M | 3.15M | 4.00M | 4.84M | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current assets | 4.67M | 4.77M | 4.06M | 2.10M | 2.84M | 6.69M | 6.00M | 27.16K | 27.16K | 298.78K |
Total non-current assets | 72.16M | 78.06M | 67.52M | 53.93M | 41.27M | 44.34M | 44.85M | 2.02M | 2.42M | 3.13M |
Total assets | 329.18M | 348.46M | 276.25M | 207.67M | 127.09M | 88.87M | 108.01M | 23.68M | 23.71M | 27.22M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 182K | 142.83K | 142.83K | 142.83K | 142.83K | 142.83K | 142.83K | 145.15K | 145.15K | 75.55K |
Short term debt | 862.99K | 905.36K | 591.08K | 365.68K | 229.07K | 29.98K | 0 | 6.12M | 30.27K | 13.84K |
Total current liabilities | 49.80M | 39.26M | 30.37M | 19.94M | 14.02M | 9.62M | 9.44M | 11.22M | 4.21M | 4.19M |
| Non-current liabilities: | ||||||||||
Long term debt | 140.37M | 153.53M | 102.32M | 97.30M | 84.50M | 44.19M | 42.97M | 14.13M | 15.75M | 14.95M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 2.10M | 1.85M | 397.35K | 54.88K | 106.57K | 53.40M | 12.72M | 8.08M | 92.42K | 559.97K |
Total non-current liabilities | 144.17M | 157.22M | 104.70M | 99.47M | 86.86M | 59.48M | 58.24M | 16.91M | 18.67M | 17.02M |
Total liabilities | 193.97M | 196.48M | 135.08M | 119.42M | 100.89M | 69.10M | 67.68M | 28.14M | 22.89M | 21.21M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |